HALO : Halozyme Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-03-11 |
|---|---|---|---|---|
| 2022 | $36.13 | $34.67 | $38.92 | 4.06% |
| 2023 | $61.71 | $40.44 | $96.4 | 77.74% |
| 2024 | $120.02 | $103.47 | $124.77 | 245.67% |
| 2025 | $120.33 | $117.34 | $123.73 | 246.56% |
| 2026 | $113.35 | $110.75 | $116.74 | 226.47% |
| 2027 | $105.78 | $98.55 | $110.63 | 204.68% |
| 2028 | $93.45 | $91.16 | $98.52 | 169.16% |
| 2029 | $107.2 | $100.98 | $109.79 | 208.77% |
| 2030 | $109.36 | $108.96 | $109.77 | 214.98% |
| 2031 | $112.33 | $109.03 | $115.28 | 223.54% |
| 2032 | $115.66 | $115.5 | $115.8 | 233.12% |
The 19 Wall Street analysts offering Halozyme Therapeutics stock forecast in the last 6 months have average price target of
$60.0 with a high forecast of $68.0 and a low forecast of $42.0.
The average Halozyme Therapeutics stock forecast represents a 72.81%
increase from the last price of $34.7200012207031.
From AI system, total return is 2366.52% from 4098 forecasts.
For Halozyme Therapeutics stock forecast for 2022, 9 predictions are offered for each month of 2022 with average Halozyme Therapeutics stock
forecast of $36.13, a high forecast of $38.92, and a low forecast of $34.67.
The average Halozyme Therapeutics stock forecast 2022 represents a 4.06%
increase from the last price of $34.7200012207031.
For Halozyme Therapeutics stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Halozyme Therapeutics stock
forecast of $61.71, a high forecast of $96.4, and a low forecast of $40.44.
The average Halozyme Therapeutics stock forecast 2023 represents a 77.74%
increase from the last price of $34.7200012207031.
For Halozyme Therapeutics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Halozyme Therapeutics stock
forecast of $120.33, a high forecast of $123.73, and a low forecast of $117.34.
The average Halozyme Therapeutics stock forecast 2025 represents a 246.56%
increase from the last price of $34.7200012207031.
For Halozyme Therapeutics stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Halozyme Therapeutics stock
forecast of $105.78, a high forecast of $110.63, and a low forecast of $98.55.
The average Halozyme Therapeutics stock forecast 2027 represents a 204.68%
increase from the last price of $34.7200012207031.
For Halozyme Therapeutics stock forecast for 2030, 12 predictions are offered for each month of 2030 with average Halozyme Therapeutics stock
forecast of $109.36, a high forecast of $109.77, and a low forecast of $108.96.
The average Halozyme Therapeutics stock forecast 2030 represents a 214.98%
increase from the last price of $34.7200012207031.
For Halozyme Therapeutics stock forecast for 2032 (10 year), 3 predictions are offered for each month of 2032 with average Halozyme Therapeutics stock
forecast of $115.66, a high forecast of $115.8, and a low forecast of $115.5.
The average Halozyme Therapeutics stock forecast 2032 represents a 233.12%
increase from the last price of $34.7200012207031.
Please, see more forecasts below.
HALO : Halozyme Therapeutics stock forecast by Wall Street Analysts
The average Halozyme Therapeutics stock forecast from last 6 month is $60.0, and this show a 6.5% increase in average from the prior price target of the each prediction. Also, this average forecast of $60.0 represents a 7.14% increase from the past average forecast of $56.0, 6 months ago from 3 wall street analysts.
Halozyme Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-03-14 | $37.54 | 8.12% |
| 2022-03-15 | $40.04 | 6.67% |
| 2022-03-16 | $39.54 | -1.25% |
| 2022-03-17 | $40.09 | 1.38% |
| 2022-03-18 | $39.10 | -2.47% |
HALO : Long term Halozyme Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Apr. is $34.67 , for 2023 Mar. is $44.46 , for 2026 Mar. is $115.45 , for 2027 Mar. is $108.88 , for 2031 Mar. is $109.63 , and for 2032 Mar. is $115.80.
HALO : Halozyme Therapeutics stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Apr. | $34.67 | -0.13% |
| 2022 May. | $34.73 | 0.17% |
| 2022 Jun. | $34.91 | 0.52% |
| 2022 Jul. | $35.23 | 0.90% |
| 2022 Aug. | $35.77 | 1.53% |
| 2022 Sep. | $36.28 | 1.44% |
| 2022 Oct. | $36.93 | 1.80% |
| 2022 Nov. | $37.72 | 2.13% |
| 2022 Dec. | $38.92 | 3.18% |
HALO : Halozyme Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $40.44 | 3.89% |
| 2023 Feb. | $42.25 | 4.48% |
| 2023 Mar. | $44.46 | 5.25% |
| 2023 Apr. | $47.22 | 6.20% |
| 2023 May. | $50.56 | 7.07% |
| 2023 Jun. | $54.43 | 7.66% |
| 2023 Jul. | $59.13 | 8.62% |
| 2023 Aug. | $64.94 | 9.83% |
| 2023 Sep. | $72.06 | 10.97% |
| 2023 Oct. | $80.13 | 11.19% |
| 2023 Nov. | $88.51 | 10.45% |
| 2023 Dec. | $96.40 | 8.92% |
HALO : Halozyme Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $103.47 | 7.34% |
| 2024 Feb. | $109.69 | 6.01% |
| 2024 Mar. | $114.94 | 4.78% |
| 2024 Apr. | $119.19 | 3.71% |
| 2024 May. | $122.19 | 2.51% |
| 2024 Jun. | $123.93 | 1.42% |
| 2024 Jul. | $124.65 | 0.58% |
| 2024 Aug. | $124.77 | 0.09% |
| 2024 Sep. | $124.62 | -0.12% |
| 2024 Oct. | $124.43 | -0.16% |
| 2024 Nov. | $124.25 | -0.14% |
| 2024 Dec. | $124.06 | -0.16% |
HALO : Halozyme Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $123.73 | -0.26% |
| 2025 Feb. | $123.13 | -0.49% |
| 2025 Mar. | $122.31 | -0.66% |
| 2025 Apr. | $121.56 | -0.61% |
| 2025 May. | $120.90 | -0.55% |
| 2025 Jun. | $120.34 | -0.46% |
| 2025 Jul. | $119.86 | -0.39% |
| 2025 Aug. | $119.42 | -0.37% |
| 2025 Sep. | $118.95 | -0.39% |
| 2025 Oct. | $118.46 | -0.42% |
| 2025 Nov. | $117.92 | -0.46% |
| 2025 Dec. | $117.34 | -0.49% |
HALO : Halozyme Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $116.74 | -0.51% |
| 2026 Feb. | $116.11 | -0.53% |
| 2026 Mar. | $115.45 | -0.57% |
| 2026 Apr. | $114.76 | -0.60% |
| 2026 May. | $114.05 | -0.62% |
| 2026 Jun. | $113.34 | -0.62% |
| 2026 Jul. | $112.69 | -0.57% |
| 2026 Aug. | $112.13 | -0.50% |
| 2026 Sep. | $111.68 | -0.40% |
| 2026 Oct. | $111.36 | -0.28% |
| 2026 Nov. | $111.13 | -0.21% |
| 2026 Dec. | $110.75 | -0.34% |
HALO : Halozyme Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $110.63 | -0.11% |
| 2027 Feb. | $109.95 | -0.61% |
| 2027 Mar. | $108.88 | -0.98% |
| 2027 Apr. | $107.78 | -1.00% |
| 2027 May. | $106.91 | -0.81% |
| 2027 Jun. | $106.24 | -0.63% |
| 2027 Jul. | $105.71 | -0.49% |
| 2027 Aug. | $105.19 | -0.49% |
| 2027 Sep. | $104.58 | -0.59% |
| 2027 Oct. | $103.53 | -1.00% |
| 2027 Nov. | $101.45 | -2.01% |
| 2027 Dec. | $98.55 | -2.86% |
HALO : Halozyme Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $95.98 | -2.62% |
| 2028 Feb. | $94.16 | -1.89% |
| 2028 Mar. | $92.92 | -1.33% |
| 2028 Apr. | $92.03 | -0.95% |
| 2028 May. | $91.44 | -0.64% |
| 2028 Jun. | $91.16 | -0.30% |
| 2028 Jul. | $91.20 | 0.04% |
| 2028 Aug. | $91.61 | 0.45% |
| 2028 Sep. | $92.48 | 0.95% |
| 2028 Oct. | $93.93 | 1.57% |
| 2028 Nov. | $96.01 | 2.21% |
| 2028 Dec. | $98.52 | 2.62% |
HALO : Halozyme Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $100.98 | 2.49% |
| 2029 Feb. | $103.03 | 2.03% |
| 2029 Mar. | $104.69 | 1.61% |
| 2029 Apr. | $106.03 | 1.28% |
| 2029 May. | $107.14 | 1.04% |
| 2029 Jun. | $108.02 | 0.82% |
| 2029 Jul. | $108.69 | 0.62% |
| 2029 Aug. | $109.17 | 0.44% |
| 2029 Sep. | $109.48 | 0.29% |
| 2029 Oct. | $109.67 | 0.17% |
| 2029 Nov. | $109.76 | 0.09% |
| 2029 Dec. | $109.79 | 0.03% |
HALO : Halozyme Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $109.77 | -0.02% |
| 2030 Feb. | $109.72 | -0.04% |
| 2030 Mar. | $109.66 | -0.06% |
| 2030 Apr. | $109.58 | -0.07% |
| 2030 May. | $109.50 | -0.07% |
| 2030 Jun. | $109.42 | -0.08% |
| 2030 Jul. | $109.33 | -0.08% |
| 2030 Aug. | $109.23 | -0.09% |
| 2030 Sep. | $109.13 | -0.09% |
| 2030 Oct. | $109.05 | -0.08% |
| 2030 Nov. | $108.98 | -0.06% |
| 2030 Dec. | $108.96 | -0.02% |
HALO : Halozyme Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $109.03 | 0.06% |
| 2031 Feb. | $109.24 | 0.20% |
| 2031 Mar. | $109.63 | 0.36% |
| 2031 Apr. | $110.22 | 0.54% |
| 2031 May. | $111.09 | 0.79% |
| 2031 Jun. | $112.19 | 0.99% |
| 2031 Jul. | $113.20 | 0.90% |
| 2031 Aug. | $113.92 | 0.64% |
| 2031 Sep. | $114.41 | 0.43% |
| 2031 Oct. | $114.76 | 0.31% |
| 2031 Nov. | $115.04 | 0.24% |
| 2031 Dec. | $115.28 | 0.21% |
HALO : Halozyme Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $115.50 | 0.19% |
| 2032 Feb. | $115.67 | 0.15% |
| 2032 Mar. | $115.80 | 0.11% |
Financial Data for Halozyme Therapeutics stock
Frequently Asked Questions about Halozyme Therapeutics stock forecast
Is Halozyme Therapeutics a good long term stock?
From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock cannot be a good investment choice. According to Tudal, the Halozyme Therapeutics stock price forecast for 2022 Apr. is $34.6734978701948 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to Tudal, the Halozyme Therapeutics stock price forecast for 2023 Mar. is $44.4641918890128 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to Tudal, the Halozyme Therapeutics stock price forecast for 2026 Mar. is $115.453778830961 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to Tudal, the Halozyme Therapeutics stock price forecast for 2027 Mar. is $108.877639193681 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to Tudal, the Halozyme Therapeutics stock price forecast for 2031 Mar. is $109.633793829685 From Halozyme Therapeutics stock forecast , Halozyme Therapeutics (HALO) stock can be a good investment choice. According to Tudal, the Halozyme Therapeutics stock price forecast for 2032 Mar. is $115.803741330813
Is Halozyme Therapeutics stock overvalued?
Halozyme Therapeutics (HALO) stock is expected to go UP . Therefore, Tudal would say that Halozyme Therapeutics (HALO) stock is NOT overvalued.
Will Halozyme Therapeutics stock price go up?
Yes. The Halozyme Therapeutics stock price forecast for 2023 Mar. is $44.4641918890128
Is Halozyme Therapeutics stock a good buy now?
Since closing price on 2022-03-11 is $34.7200012207031 and forecast for 2023 Mar. is $44.46, Halozyme Therapeutics stock is a good 1 year investment.